Triptan Therapy in Migraine
NEJM 363:63-70, Loder,E., 2010
The Safety of Triptans in the Treatment of Patients with Migraine
Am J Med 112:135-140, Jamieson,D.G., 2002
Stroke Prevention in Symptomatic Large Artery Intracranial Atherosclerosis Practice Advisory
Neurol 98:486-498, Turan, T.N.,et al, 2022
Controversy and Progress in Alzheimers Disease - FDA Approval of Aducanumab
NEJM 385:doi:10.1056/NEJMp2111320, Rabinovici, G.D., 2021
Glucocorticoid-Associated Worsening in Reversible Cerebral Vasoconstriction Syndrome
Neurol 88:228-236, Singhal, A.B. & Topcuoglu, M.A., 2017
Pacemakers in MRI for the Neuroradiologist
AJNR 38:2222-2230, Korutz, A.W.,et al, 2017
Safety of Magnetic Resonance Imaging in Patients with Cardiac Devices
NEJM 377:2555-2564, Nazarian, S.,et al, 2017
Clinical Relevance of Microbleeds in Acute Stroke Thrombolysis
Neurol 87:1534-1541, Charidimou, A.,et al, 2016
Thrombolysis Despite Recent Stroke
Stroke 44:1736-1738, Alhazzaa, M.,et al, 2013
An unusual cause of stroke and hypoxia
BMJ 342:c7200, Bell, S.L. & Eveson, D.J., 2011
Statin Use Following Intracerebral Hemorrhage
Arch Neurol 68:573-579, Westover, M.B.,et al, 2011
Are all IV thrombolysis exclusion criteria necessary? Being SMART about evidence-based medicine
Neurol 76:1780-1781, Tong, D., 2011
Cerebral Amyloid Angiopathy in the Elderly
Ann Neurol 70:871-880, Viswanathan, A. and Greenberg, S.M., 2011
Responding to Medical Events During Commercial Airline Flights
NEJM 346:1067-1073, Gendreau,M.A. &DeJohn,C., 2002
AAC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins
Stroke 33:2337-2341, Pasternak,R.C.,et al, 2002